Search - tctmd.com

Displaying 81 - 100 of 2435

Sort: Relevancy | Date

Presentation TCT 2024

TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis

Presenter: Yuanji Ma

October 29, 2024

Presentation TCT 2024

TCT 494: Between a Stent and a Hard Place: Insights Into Percutaneous Coronary Interventions and In-Stent Restenosis in Cancer Patients

Presenter: Teodora Donisan

October 29, 2024

Presentation TCT 2024

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 29, 2024

Presentation TCT 2024

TCT 432: Long-Term Outcomes of Ultrathin Struts Biodegradable Polymer Sirolimus-Eluting Stent for Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Bernardo Cortese

October 29, 2024

Presentation TCT 2024

TCT 430: Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating in the Treatment of Native Coronary Artery Lesions: Inspiron Real Life II and Latitude Trials

Presenter: Paulo Caramori

October 29, 2024

Presentation TCT 2024

TCT 429: Percutaneous Coronary Intervention With Ridaforolimus-Eluting-Stents in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis

Presenter: Edmundo Damiani Bertoli

October 29, 2024

Presentation TCT 2024

TCT 428: Efficacy and Safety of a Novel Ultra-Thin Arsenic Trioxide-Tacrolimus Eluting Stent in Porcine Coronary Artery

Presenter: Han Chen

October 29, 2024

Presentation TCT 2024

Balancing Clinical Outcomes with Utilization in Clinical Practice - Case Example = The Agent ISR DCB

Presenter: Robert Yeh

October 29, 2024

Presentation TCT 2024

TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis

Presenter: Leonardo Sinnott Silva

October 29, 2024

Presentation TCT 2024

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

Presenter: Han Chen

October 29, 2024

Presentation TCT 2024

TCT 426: One-Year Clinical Outcome of Prasugrel Monotherapy After PCI for Chronic Coronary Syndrome in Japanese Population

Presenter: KOTARO MIYASHITA

October 29, 2024

Presentation TCT 2024

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

Presenter: Kazuki Aihara

October 29, 2024

Presentation TCT 2024

TCT 423: Biodegradable-Polymer Coated Sirolimus-Eluting Stents in Diabetic Patients: Insights From the S-FLEX UK II Registry

Presenter: Aayush Singal

October 29, 2024

Presentation TCT 2024

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

Presenter: Michael Joner

October 29, 2024

Presentation TCT 2024

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

Presenter: Lei Song

October 29, 2024

Presentation TCT 2024

TCT 370: Clinical Safety and Angiographic Performance of the Fantom Encore Bioresorbable Scaffold: Insights From an Italian Center

Presenter: Francesco Amata

October 29, 2024

Presentation TCT 2024

TCT 369: Functional Hemodynamic Assessment of a Novel Endoluminal Fibrillated Polymeric Scaffold up to Full Resorption Within 12 Months in a Preclinical In-Vivo Setting

Presenter: KOTARO MIYASHITA

October 29, 2024

Presentation TCT 2024

TCT 368: Coronary Physiology After Drug-Eluting Absorbable Metallic Scaffold

Presenter: Ryan Wallace

October 29, 2024

Presentation TCT 2024

TCT 367: Impact of Optical Coherence Tomography Guidance During Bioresorbable Scaffold Implantation: Decision-Making and Post-Procedure Outcomes

Presenter: Jiasheng Yin

October 29, 2024

Presentation TCT 2024

TCT 366: Preliminary 24-Month Results of the Magmaris Resorbable Magnesium Scaffold (RMS) in Long and Multivessel Disease: Data From the Italian IT-MASTERS Registry

Presenter: Stefano Galli

October 29, 2024

Advertisement

TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis

TCT 494: Between a Stent and a Hard Place: Insights Into Percutaneous Coronary Interventions and In-Stent Restenosis in Cancer Patients

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

TCT 432: Long-Term Outcomes of Ultrathin Struts Biodegradable Polymer Sirolimus-Eluting Stent for Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TCT 430: Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating in the Treatment of Native Coronary Artery Lesions: Inspiron Real Life II and Latitude Trials

TCT 429: Percutaneous Coronary Intervention With Ridaforolimus-Eluting-Stents in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis

TCT 428: Efficacy and Safety of a Novel Ultra-Thin Arsenic Trioxide-Tacrolimus Eluting Stent in Porcine Coronary Artery

Balancing Clinical Outcomes with Utilization in Clinical Practice - Case Example = The Agent ISR DCB

TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

TCT 426: One-Year Clinical Outcome of Prasugrel Monotherapy After PCI for Chronic Coronary Syndrome in Japanese Population

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

TCT 423: Biodegradable-Polymer Coated Sirolimus-Eluting Stents in Diabetic Patients: Insights From the S-FLEX UK II Registry

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

TCT 370: Clinical Safety and Angiographic Performance of the Fantom Encore Bioresorbable Scaffold: Insights From an Italian Center

TCT 369: Functional Hemodynamic Assessment of a Novel Endoluminal Fibrillated Polymeric Scaffold up to Full Resorption Within 12 Months in a Preclinical In-Vivo Setting

TCT 368: Coronary Physiology After Drug-Eluting Absorbable Metallic Scaffold

TCT 367: Impact of Optical Coherence Tomography Guidance During Bioresorbable Scaffold Implantation: Decision-Making and Post-Procedure Outcomes

TCT 366: Preliminary 24-Month Results of the Magmaris Resorbable Magnesium Scaffold (RMS) in Long and Multivessel Disease: Data From the Italian IT-MASTERS Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content